Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
29
|
pubmed:dateCreated |
1983-9-9
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0755-4982
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1799-800
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6224193-Antilymphocyte Serum,
pubmed-meshheading:6224193-Blood Transfusion,
pubmed-meshheading:6224193-Graft Rejection,
pubmed-meshheading:6224193-HLA Antigens,
pubmed-meshheading:6224193-Histocompatibility Testing,
pubmed-meshheading:6224193-Humans,
pubmed-meshheading:6224193-Kidney Transplantation,
pubmed-meshheading:6224193-Lymphocytes,
pubmed-meshheading:6224193-Prognosis
|
pubmed:articleTitle |
[Crossmatching before renal transplantation. Development of a dogma].
|
pubmed:publicationType |
Journal Article
|